Vascular Perfusion Solutions Inc (VPS), developer of the VP.S ENCORE platform designed to preserve donor hearts and other organs for extended durations, announced on Wednesday that it has partnered with the Wyss Institute at Harvard University, the University of Colorado, and the University of Wyoming under the Advanced Research Projects Agency for Health (ARPA-H) Tissue Preservation under Stress (TiPS) project.

This collaboration is intended to advance novel biostasis compounds to improve organ preservation.

VPS will conduct translational testing of these compounds to develop an advanced perfusion solution designed to extend organ preservation time and increase donor organ utilisation.

Rafael J Veraza, PhD, MPH, VPS CEO and president, and co-investigator on the grant, said: "Extending the safe preservation window is essential to improving access and equity in transplantation. By working with the Wyss Institute and our academic partners, we aim to translate cutting-edge biostasis science into practical, scalable solutions."